Clinical Trial

OXXYNEA® GS: Study for Glycaemia Management

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 18, 2025 (before its estimated October 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of this study is to develop a proof of concept establishing a causal relationship between glycemia improvement through combination of polyphenols-rich botanical extracts or polyphenols-rich botanical extracts associated with white kidney bean extract and chromimum picolinate + zinc bisglycinate with chronic supplementation. Chronic glycemia improvement will be assessed by following the evolution of HbA1c, postprandial glucose and insulin kinetics, and questionnaires. The study design is double blinded randomized with 3 arms and 29 volunteers per arm.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-06-29; most recent amendment 2025-09-12.
Status change: Recruiting → Active, Not Recruiting 2025-09-12
Status change: Not Yet Recruiting → Recruiting 2023-09-11
Trial Details
NCT Number NCT05926947
Lead Sponsor Fytexia
Conditions Prediabetic State, Overweight
Enrollment 87 participants
Start Date 2023-07-05
Primary Completion 2025-10-30 (estimated)
Study Completion 2025-12-15 (estimated)
Updated on ClinicalTrials.gov 2025-09-18